SpliSense
PrivateLast Round
Grant
Jun 16, 2026
Total Funding Raised
$38.4M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
SpliSense is a biotechnology company that develops innovative RNA-based therapies using antisense oligonucleotides to treat cystic fibrosis and other genetic pulmonary diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SpliSense Comparables
Compare SpliSense with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spirovant Sciences | 80% | |
| ReCode Therapeutics | 79% | |
| ProQR Therapeutics | 78% | |
SpliSense Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 16, 2026 | ||||
| Grant | Apr 3, 2024 | ||||
| Series B | May 13, 2021 |
SpliSense Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Biotech Fund | Series B, Grant |
| OrbiMed | Grant, Series B |
| Integra Holdings | Series B, Series A, Grant |
| Cystic Fibrosis Foundation | Series B, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 90% MoM.
- Jun 16, 2026
Raised $13M with Cystic Fibrosis Foundation leading.
SpliSense Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SpliSense's valuation, stock price, and market status.